Recently, RegIV overexpression was reported to be associated with the initiation and progression of pancreatic cancer, and was suggested as a promising tumor marker to screen early stage PC and target for adjuvant therapy in PC [28], [30]. This evidence concerns the gene REG4 and familial pancreatic carcinoma.